{{Rsnum
|rsid=2859998
|Gene=UBXN2B
|Chromosome=8
|position=58411603
|Orientation=plus
|GMAF=0.3678
|Gene_s=UBXN2B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 42.9 | 49.1
| HCB | 21.9 | 51.8 | 26.3
| JPT | 37.5 | 42.9 | 19.6
| YRI | 3.4 | 36.1 | 60.5
| ASW | 3.5 | 31.6 | 64.9
| CHB | 21.9 | 51.8 | 26.3
| CHD | 17.4 | 52.3 | 30.3
| GIH | 14.0 | 48.0 | 38.0
| LWK | 6.4 | 38.5 | 55.0
| MEX | 36.8 | 49.1 | 14.0
| MKK | 8.3 | 41.7 | 50.0
| TSI | 5.0 | 38.6 | 56.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23496005
  |Trait=Narcolepsy with cataplexy
  |Title=Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study.
  |RiskAllele=
  |Pval=1E-7
  |OR=4.41
  |ORtxt=[NR] unit decrease
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}